Shibata J, Hayashida T, Ikebe M, Sato K, Noumaru S, Fujiyama S, Sato T, Hashiguchi O
Third Dept. of Internal Medicine, Kumamoto University School of Medicine.
Gan To Kagaku Ryoho. 1994 Aug;21(10):1669-72.
A 65-year-old male with hepatocellular carcinoma was admitted to our hospital. Hepatic angiography showed a hypervascular tumor 8 cm in diameter in the right lobe of the liver with tumor emboli in the inferior vena cava and right atrium. Then, two chemoembolization treatments using gelform and cisplatin suspended in Lipiodol were performed. Although the size of the main tumor in the liver and tumor emboli was reduced, 6 months after the initial chemoembolization the serum levels of alfa-fetoprotein (AFP) and plasma des-gamma-carboxy prothrombin (DCP) rose to 14,000 ng/ml and 6.4 AU/ml, respectively, and multiple lung metastases were detected by CT scan. Then, 200 mg/day of UFT was administered orally. Four months after the administration, the levels of AFP and DCP markedly decreased to 95 ng/ml and 0.0 AU/ml, respectively, and the lung metastases and tumor emboli disappeared. Moreover, there were no side-effects including liver dysfunction.
一名65岁的肝细胞癌男性患者入住我院。肝血管造影显示肝脏右叶有一个直径8厘米的高血运肿瘤,下腔静脉和右心房有肿瘤栓子。随后,进行了两次使用明胶海绵和顺铂混悬于碘油中的化疗栓塞治疗。尽管肝脏主要肿瘤和肿瘤栓子的大小有所减小,但在初次化疗栓塞6个月后,甲胎蛋白(AFP)血清水平和血浆去γ-羧基凝血酶原(DCP)分别升至14,000 ng/ml和6.4 AU/ml,CT扫描检测到多发肺转移。然后,口服UFT 200毫克/天。给药4个月后,AFP和DCP水平分别显著降至95 ng/ml和0.0 AU/ml,肺转移灶和肿瘤栓子消失。此外,未出现包括肝功能障碍在内的副作用。